Similarly, the levels of mRNA related to liver fibrosis (Col1A1, Acta2, Timp1, and Tgfb1) were significantly increased in the DM group, which were significantly reduced by the LFD treatment. This evidence concerns the gene ACTA2 and Hepatic fibrosis.